Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD
Clinical trial NCT06924710 · RECRUITING
Trial details
- NCT number
- NCT06924710
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-06
- Primary completion
- 2029-06-15
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.